Dr. Barry Dworkin

Drug combo boosts advanced HER-2 breast cancer survival

Madely Health Headlines Commentary for December 14, 2009

Source:

Drug Combo boosts advanced breast cancer survival

Comment:

This approach to treatment applies only to HER-2 breast cancers that according to the article represents 1 in 4 breast cancers.

Related posts:

  1. Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
  2. More information needed about woman's breast cancer before slamming Ontario Government for not covering breast-cancer drug
  3. Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study
  4. New optical imaging technique helps identify breast cancer subtypes and how well they respond to treatment in real time

Leave a Reply